Nearly half of medtech executives polled in a recent survey said their companies are prepared for the second wave of the COVID-19 pandemic that is sweeping the globe. Forty-eight percent of the 71 MedExecWomen Fall Forum attendees who responded to the question reported their companies’ readiness hinged on scalable remote commercial capabilities, a bolstered supply chain […]
Boston Consulting Group
Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) were named in the Boston Consulting Group’s list of the 50 most innovative companies this year at the 20 and 42 spot, respectively. Apple (NSDQ:AAPL) and Google (NSDQ:GOOG) took the top 2 spots on the list. Other notable entries were Gilead at number 8, Bayer‘s (ETR:BAYN) at 11, Biogen (NSDQ:BIIB) at […]
As publicly traded firms ready their year-end financial statements this month it’s clear that the med-tech industry’s high-flying days aren’t coming back any time soon.
Wall Street analysts expect companies in the sector to release cautious forecasts for sales and earnings in 2012, reflecting a series of factors conspiring to put pressure on their top and bottom lines. Lower procedure volumes, pricing pressure and the unstable European economy all play a part, according to Barclay’s Capital analyst Adam Feinstein.